Physician profile
Geoffrey Stone Landis
NPI 1982645719
$306,574.93
in general payments reported to CMS, 2019-2025
21 companies · $4,407 in 2025
The $4,407 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $28K · 2021: $55K · 2022: $140K · 2023: $36K · 2024: $9,009 · 2025: $4,407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $28K · Acquisitions: $13K · Consulting Fee: $6,000 · Food and Beverage: $1,946 · Travel and Lodging: $89.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $28,148.52 |
| Acquisitions | $13,007.06 |
| Consulting Fee | $6,000.00 |
| Food and Beverage | $1,946.07 |
| Travel and Lodging | $89.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $134,850.66 | 2022-2025 | Quantum, Avenger Radial Head, +4 Stems, Triway |
| Stryker Corporation | $65,632.87 | 2019-2025 | Ortholoc 3di Crosscheck, Inbone, Citrefix |
| In2bones USA, LLC | $59,878.67 | 2019-2022 | |
| Wright Medical Technology, INC. | $43,773.14 | 2019-2020 | |
| 4web, INC. | $1,249.16 | 2019 | |
| Pacira Therapeutics, INC. | $210.48 | 2019-2021 | |
| Treace Medical Concepts, INC. | $197.09 | 2023-2025 | |
| Theramicro, INC. | $140.75 | 2025 | Tekbrace Solo, Allostat Gfx |
| Restor3d, INC. | $135.55 | 2025 | |
| Paragon 28, INC. | $134.37 | 2024-2025 | Ttc Nail, Ankle Fracture |
| Medline Industries Lp | $76.40 | 2021 | |
| Horizon Therapeutics Plc | $57.73 | 2019-2020 | |
| Depuy Synthes Sales INC. | $50.19 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $49.17 | 2025 | Exparel |
| Orthofix Medical, INC. | $39.96 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $26.50 | 2025 | Ethicon |
| Smith+Nephew, INC. | $20.65 | 2022 | |
| Zyla Life Sciences, INC. | $13.33 | 2019 | |
| Mimedx Group, INC. | $13.12 | 2024 | |
| Biotissue Holdings INC. | $12.57 | 2021 | |
| Davol INC. | $12.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Geoffrey Landis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.